Our data showed that higher expression of α-SMA or PDGFRα was correlated with worse overall survival, elevated cancer progression and enhanced lymph node metastasis (Fig. 1a–c, Supplementary Fig. 1a–c). The gene discussed is ACTA1; the disease is cancer.